Presentation is loading. Please wait.

Presentation is loading. Please wait.

Baseline Characteristics of Study Populations

Published byGuus Timmermans Modified over 5 years ago

Similar presentations

Presentation on theme: "Baseline Characteristics of Study Populations"— Presentation transcript:

1 Baseline Characteristics of Study Populations
Nadeem Sarwar, et al. Circulation 2006;115:

2 Baseline Correlates of Log Triglycerides Levels in Controls
Nadeem Sarwar, et al. Circulation 2006;115:

3 Relative Odds of CHD Among Patients Who Had Log-Triglyceride Levels in the Top Third of the Distribution of Values for Controls Compared With Those Who Had Values in the Bottom Third of the Same Distribution Nadeem Sarwar, et al. Circulation 2006;115:

4 Characteristics of 27 Previously Published Prospective Studies in Western Populations (Plus the 2 Present Studies) of Triglycerides and CHD Nadeem Sarwar, et al. Circulation 2006;115:

5 Available prospective studies of triglycerides and CHD in essentially general populations
Nadeem Sarwar, et al. Circulation 2006;115:

6 Studies of the risk of CHD in individuals in the top vs bottom third of usual log-triglyceride values grouped according to several study characteristics Nadeem Sarwar, et al. Circulation 2006;115:

Download ppt "Baseline Characteristics of Study Populations"

Similar presentations

Sibbing D, et al. J Am Coll Cardiol 2009;53:849-56.

Sibbing D, et al. J Am Coll Cardiol 2009;53:
Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:1948-55.

Baseline Characteristics According to CET Rate Marianne Zeller, et al. J Am Coll Cardiol 2007;50:
Slide Source: Lipids Online Slide Library www.lipidsonline.org Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.

Slide Source: Lipids Online Slide Library Prospective Pravastatin Pooling Project: Coronary Event Rates in CARE and LIPID Patients.
Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.

Management of Elevated Cholesterol in the Primary Prevention Group of Adult Japanese (MEGA) Trial MEGA Trial Presented at The American Heart Association.
Ho PM, et al. JAMA 2009;301:937-44. Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:937-44.

Ho PM, et al. JAMA 2009;301: Baseline Characteristics of Patients Taking Clopidogrel After Hospital Discharge a Ho PM, et al. JAMA 2009;301:
Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:1556-1563.

Baseline Characteristics of Cases, Controls, and Entire VA-HIT Population James D. Otvos, et al, Circulation 2006;113:
Solomon Tesfaye et al N Engl J Med 2005;352:341- 50 Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.

Solomon Tesfaye et al N Engl J Med 2005;352: Comparison of Baseline Data in 1819 Patients According to Whether There Was an Assessment for Neuropathy.
Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:1851-1857.

Baseline Characteristics of the Patient Population (n=525) Colin Berry, et al. Circulation 2007;115:
Charlotte Kragelund et al N Engl J Med 2005;352:666- 75 Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.

Charlotte Kragelund et al N Engl J Med 2005;352: Baseline Clinical Characteristics According to Quartiles of NT-pro-BNP.
Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.

Baseline Characteristics of 1994 of Men With Incident CHD (1994 to 2000) and Matched Control Subjects From the Health Professionals Follow-up Study T.
11.09.15 I can identify characteristics of population growth and distribution in Argentina, Bolivia, and Guyana.

I can identify characteristics of population growth and distribution in Argentina, Bolivia, and Guyana.
Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.
Search strategy and results Amir Kashani, et al. Circulation. 2006;114:2788-2797.

Search strategy and results Amir Kashani, et al. Circulation. 2006;114:
Ann Intern Med. 2010;153(7): doi: / Figure Legend:

Ann Intern Med. 2010;153(7): doi: / Figure Legend:
Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Peter W. Kim, Yu-te Wu, Charles Cooper, George Rochester, Thamban.

Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Peter W. Kim, Yu-te Wu, Charles Cooper, George Rochester, Thamban.
Should we move from Lipids to Lipoproteins, from Dyslipidemia to Dyslipoproteinemia in future guidelines for CVD?

Should we move from Lipids to Lipoproteins, from Dyslipidemia to Dyslipoproteinemia in future guidelines for CVD?
Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Peter W. Kim, Yu-te Wu, Charles Cooper, George Rochester, Thamban.

Meta-Analysis of a Possible Signal of Increased Mortality Associated with Cefepime Use Peter W. Kim, Yu-te Wu, Charles Cooper, George Rochester, Thamban.
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
(CMR vs. guidelines, p < 0.001)

(CMR vs. guidelines, p < 0.001)
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Similar presentations

Ads by Google